Biocryst医药

7.22
-0.03
-0.41%
BCRX
高 7.32开 7.25量 329.22万股总市值 15.16亿
低 7.08换 1.57%额 2364.23万市盈TTM 亏损
分时
5日
日K
周K
月K
季K
年K
  • MA
  • BOLL
  • 成交量
  • MACD
  • KDJ
  • RSI
  • WR
  • BIAS
  • CCI
  • PSY
讨论
资讯
公告
资料
财务
相关
用户头像
Biocryst医药(BCRX)
10-01 20:05  
$Biocryst医药(BCRX)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001140361-25-036875  Act: 34  Size: 1 MB 网页链接
用户头像
Biocryst医药(BCRX)
09-20 00:25  
$Biocryst医药(BCRX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001193805-25-001316  Act: 34  Size: 16 KB 网页链接
用户头像
Biocryst医药(BCRX)
09-04 04:35  
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000882796-25-000013  Size: 4 KB 网页链接
用户头像
Biocryst医药(BCRX)
09-04 04:15  
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000882796-25-000003  Size: 4 KB 网页链接
用户头像
Biocryst医药(BCRX)
09-04 04:15  
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000882796-25-000005  Size: 4 KB 网页链接
用户头像
Biocryst医药(BCRX)
08-15 20:35  
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-25-020491  Size: 11 KB 网页链接
用户头像
Biocryst医药(BCRX)
08-14 00:25  
$Biocryst医药(BCRX)$ 144 Report of proposed sale of securities Accession Number: 0001959173-25-005151  Act: 33  Size: 4 KB 网页链接
用户头像
Biocryst医药(BCRX)
08-13 04:15  
$Biocryst医药(BCRX)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001171843-25-005329  Act: 33  Size: 208 KB 网页链接
用户头像
Biocryst医药(BCRX)
08-11 19:15  
$Biocryst医药(BCRX)$ 8-K Current report, item 5.02 Accession Number: 0001171843-25-005265  Act: 34  Size: 187 KB 网页链接
用户头像
Biocryst医药(BCRX)
08-06 04:05  
$Biocryst医药(BCRX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-25-037795  Act: 34  Size: 9 MB 网页链接
用户头像
Biocryst医药(BCRX)
08-04 19:15  
$Biocryst医药(BCRX)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001171843-25-004977  Act: 34  Size: 357 KB 网页链接
用户头像
Biocryst医药(BCRX)
07-31 19:05  
$Biocryst医药(BCRX)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001171843-25-004869  Act: 34  Size: 235 KB 网页链接
用户头像
Biocryst医药(BCRX)
07-29 04:15  
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-25-019632  Size: 7 KB 网页链接
用户头像
Biocryst医药(BCRX)
07-12 04:45  
$Biocryst医药(BCRX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001171843-25-004435  Size: 11 KB 网页链接
用户头像
Biocryst医药(BCRX)
07-07 19:05  
$Biocryst医药(BCRX)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001171843-25-004324  Act: 34  Size: 230 KB 网页链接
用户头像
Biocryst医药(BCRX)
06-30 19:45  
$Biocryst医药(BCRX)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001140361-25-024089  Act: 34  Size: 2 MB 网页链接
用户头像
Biocryst医药(BCRX)
06-27 19:15  
$Biocryst医药(BCRX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001171843-25-004186  Act: 34  Size: 240 KB 网页链接
用户头像
Biocryst医药(BCRX)
06-25 19:05  
$Biocryst医药(BCRX)$ 8-K Current report, item 8.01 Accession Number: 0001171843-25-004091  Act: 34  Size: 188 KB 网页链接
用户头像
Biocryst医药(BCRX)
06-17 04:25  
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001171843-25-003911  Size: 7 KB 网页链接
用户头像
Biocryst医药(BCRX)
06-17 04:25  
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001171843-25-003912  Size: 16 KB 网页链接